Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|3|1327-1332

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.3, 2015-01, pp. : 1327-1332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic usage of VH gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia

By Tobin Gerard   Rosenquist Richard  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 217-228

Humana Press, Inc

Access to resources Recommend Favorite

The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis

By Nordstrom Beth L.   Knopf Kevin B.   Teltsch Dana Y.   Engle Robert   Beygi Hooman   Sterchele James A.  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1266-1273

Informa Healthcare

Access to resources Recommend Favorite

Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China

By            

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1266-1272

Spandidos Publications

Access to resources Recommend Favorite

Prognostic and Predictive Indicators in Chronic Lymphocytic Leukemia(

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 101-127

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients with chronic lymphocytic leukemia

By Norin Stefan   Kimby Eva   Lundin Jeanette  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 820-825

Humana Press, Inc

Access to resources Recommend Favorite